Sensing the Invisible

Non-invasive biomarker analysis of blood and tissue at the point of care

Previous slide

Next slide

Improving patient care through technology

IR-MED’s spectrographic AI-based technology platform introduces biomarker profiling to handheld, point of care devices, providing healthcare professionals with non-invasive, real-time analysis of blood and tissue for decision support

Play Video

Improving Patient Care Through Technology

Handheld device for the early detection of pressure injuries

~ 0 %

Accuracy in detection of Pressure Injury*

0 %

Equity for people of all skin tones

0 B$

Problem needing a solution

*Based on multicenter Interim Study

* PressureSafe is not yet available for commercial use. Expected US launch: H2/2024

Changing treatment paradigms & economics
in multi-billion dollar markets.

PressureSafe

Detection of early stage pressure injuries in patients of all skin tones.

Infrared spectrography & AI analysis platform

for real time non invasive biomarker detection and monitoring

DiaSafe

Early detection of diabetic foot ulcer

Drug Monitor

Monitoring of drug levels in the blood, without drawing blood

NoBiotics

Detection of pediatric ear infection source: viral vs. bacterial

PresureSafe(™)

Detection of early stage pressure injuries for all skin tones

DiaSafe(™)

Early detection of diabetic foot ulcer

NoBiotics(™)

Detection of pediatric ear infection source: viral vs. bacterial

Non-Invasive Drug-Level Monitor

Monitoring of drug levels in the blood, at the point of care

Latest News

IR-MED Reports 92% Efficacy for PressureSafe™ in Early, Non-Invasive, Skin Color Agnostic Detection of Pressure Injuries

IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16

AI-Driven Healthcare Revolution

IR-MED Awarded Most Innovative Non-Invasive Diagnostics Technology Developer 2023 by Corporate Vision Magazine

IR-MED Granted Patent in Israel for its AI-Driven Platform Technology: Non-Invasive Analysis of Subcutaneous Tissue

IR-MED HONORS JUNETEENTH WITH COMMITMENT TO HEALTHCARE EQUALITY: PRESSURESAFE DEVICE SEES BENEATH THE SKIN TO ADDRESS INEQUALITY IN PRESSURE INJURIES

IR-MED APPOINTS DR. LYNN ESCHENBACHER TO ITS ADVISORY BOARD AS COMPANY ADVANCES TOWARD LAUNCH OF ITS PRESSURESAFE WOUND CARE DEVICE